Abstract
Background/Objectives: Differentiating amiodarone-induced thyrotoxicosis (AIT) types remains challenging because clinical, biochemical, and imaging findings frequently overlap. This study evaluated semiquantitative technetium-99m methoxyisobutylisonitrile (MIBI) thyroid uptake using a mediastinal background region to characterize the distribution of thyroid uptake patterns in patients with AIT. Methods: In this single-centre observational study, 55 patients with AIT and 35 euthyroid controls underwent early and delayed planar MIBI thyroid scintigraphy. Semiquantitative analysis was performed using thyroid-to-background ratios (TBR). Patients were stratified into exploratory low-, intermediate-, and high-uptake groups according to TBR tertiles. Early and delayed TBR measurements, their association, and stability of relative uptake grouping were analyzed. Laboratory parameters, thyroid ultrasound, and 99mTc-pertechnetate scintigraphy were evaluated as complementary diagnostic tools. Results: Median early TBR values were 0.34 (IQR, 0.29–0.36), 0.52 (IQR, 0.43–0.57), and 0.74 (IQR, 0.66–0.83) in the low-, intermediate-, and high-uptake groups, respectively, versus 0.66 (IQR, 0.54–0.77) in controls. Early TBR was significantly lower in the low- and intermediate-uptake groups than in controls (p < 0.001 and p = 0.0066, respectively), whereas the high-uptake group did not differ significantly. Delayed TBR was lower than early TBR (median reduction 30.0%; p < 0.001). Early and delayed TBR measurements were strongly correlated (rs = 0.86, p < 0.001), and 78.2% of patients remained in the same uptake group. Conclusions: Semiquantitative MIBI analysis using a mediastinal background region provides an objective measure of thyroid uptake patterns in AIT. The strong correlation between early and delayed TBR measurements and substantial stability of relative uptake grouping indicate that the two imaging time points provide closely related semiquantitative information. These exploratory findings require external validation before routine clinical implementation.